Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes
Clinical trial NCT02912208 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02912208
- Sponsor
- Associazione Qol-one
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-11
- Primary completion
- 2017-02-02
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.